ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
Ciusss de L'Est de l'Île de Montréal
Ciusss de L'Est de l'Île de Montréal
Mayo Clinic
Massachusetts General Hospital
Wake Forest University Health Sciences
Celgene
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
University of Heidelberg Medical Center
GPCR Therapeutics, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Pfizer
Sanofi
Juno Therapeutics, a Subsidiary of Celgene
National Institutes of Health Clinical Center (CC)
University Hospital, Lille
Genentech, Inc.
University of Rochester
Medical College of Wisconsin
University of Chicago
New Valley University
University of Chicago
Brown University
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Stichting Hemato-Oncologie voor Volwassenen Nederland
Pfizer
VA Office of Research and Development
Centre Henri Becquerel
Centre Hospitalier Régional d'Orléans
University of Chicago
Hospices Civils de Lyon
European Myeloma Network B.V.
M.D. Anderson Cancer Center
Thomas Jefferson University
MGH Institute of Health Professions
Fate Therapeutics
Acerta Pharma BV
University Hospital, Lille
H. Lee Moffitt Cancer Center and Research Institute
Institut Curie
Mayo Clinic
Centre Hospitalier Universitaire, Amiens
University of Chicago
Thomas Jefferson University
Cedars-Sinai Medical Center
Memorial Sloan Kettering Cancer Center
Janssen Research & Development, LLC
Brown University
Affiliated Hospital to Academy of Military Medical Sciences
Janssen Pharmaceutical K.K.